SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-083231
Filing Date
2020-03-24
Accepted
2020-03-24 08:31:03
Documents
3
Period of Report
2020-05-05
Effectiveness Date
2020-03-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d883998ddef14a.htm DEF 14A 420773
2 GRAPHIC g883998dsp40.jpg GRAPHIC 2851
3 GRAPHIC g883998g0320112936575.jpg GRAPHIC 2611
  Complete submission text file 0001193125-20-083231.txt   429862
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 20736683
SIC: 2834 Pharmaceutical Preparations